SEC Form 4 · accession 0001209191-15-041014
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 8, 2015
Accepted (ET)
May 11, 2015 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 8, 2015 | S | 33,400 | $13.23 | D | 1,923,226 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average from 239 transactions with prices ranging from $12.80 to $13.505. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.